Novacyt NVYTF Stock
Novacyt Price Chart
Novacyt NVYTF Financial and Trading Overview
| Novacyt stock price | 0.5 USD |
| Previous Close | 0.5 USD |
| Open | 0.5 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.5 - 0.5 USD |
| 52 Week Range | 0.5 - 2.05 USD |
| Volume | 22.77K USD |
| Avg. Volume | 385 USD |
| Market Cap | 36.9M USD |
| Beta (5Y Monthly) | -2.222437 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.45 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
NVYTF Valuation Measures
| Enterprise Value | -50979876 USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.7538356 |
| Price/Book (mrq) | 0.3065604 |
| Enterprise Value/Revenue | -2.423 |
| Enterprise Value/EBITDA | 3.801 |
Trading Information
Novacyt Stock Price History
| Beta (5Y Monthly) | -2.222437 |
| 52-Week Change | -70.059% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.05 USD |
| 52 Week Low | 0.5 USD |
| 50-Day Moving Average | 0.61 USD |
| 200-Day Moving Average | 0.88 USD |
NVYTF Share Statistics
| Avg. Volume (3 month) | 385 USD |
| Avg. Daily Volume (10-Days) | 2.28K USD |
| Shares Outstanding | 70.63M |
| Float | 68.31M |
| Short Ratio | N/A |
| % Held by Insiders | 3.49% |
| % Held by Institutions | 1.59% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -122.29% |
| Operating Margin (ttm) | -74.76% |
| Gross Margin | 25.55% |
| EBITDA Margin | -63.74% |
Management Effectiveness
| Return on Assets (ttm) | -6.056% |
| Return on Equity (ttm) | -17.27% |
Income Statement
| Revenue (ttm) | 21.04M USD |
| Revenue Per Share (ttm) | 0.3 USD |
| Quarterly Revenue Growth (yoy) | -88.79% |
| Gross Profit (ttm) | 5.75M USD |
| EBITDA | -13412000 USD |
| Net Income Avi to Common (ttm) | -22201000 USD |
| Diluted EPS (ttm) | -0.38 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 87.17M USD |
| Total Cash Per Share (mrq) | 1.23 USD |
| Total Debt (mrq) | 872K USD |
| Total Debt/Equity (mrq) | 0.76 USD |
| Current Ratio (mrq) | 5.25 |
| Book Value Per Share (mrq) | 1.631 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -13729000 USD |
| Levered Free Cash Flow (ttm) | -4376375 USD |
Profile of Novacyt
| Country | United States |
| State | N/A |
| City | Vélizy-Villacoublay |
| Address | 13 Avenue Morane Saulnier |
| ZIP | 78140 |
| Phone | 33 1 39 46 51 04 |
| Website | https://www.novacyt.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 222 |
Novacyt S.A., together with its subsidiaries, provides in vitro and molecular diagnostic tests for a range of infectious diseases in the United Kingdom, rest of Europe, the United States, the Asia Pacific, the Middle East, and Africa. It operates through Primer Design, Lab21 Products, and IT-IS International segments. The Primer Design segment designs, manufactures, and markets molecular real-time qPCR testing devices and reagents in the areas of infectious diseases. The Lab21 Products segment develops, manufactures, and distributes a range of protein-based infectious disease in-vitro diagnostic device (IVD) products. The IT-IS International segment develops and manufactures PCR devices for the life sciences and food testing industry. The company was incorporated in 2006 and is based in Vélizy-Villacoublay, France.
Q&A For Novacyt Stock
What is a current NVYTF stock price?
Novacyt NVYTF stock price today per share is 0.5 USD.
How to purchase Novacyt stock?
You can buy NVYTF shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Novacyt?
The stock symbol or ticker of Novacyt is NVYTF.
Which industry does the Novacyt company belong to?
The Novacyt industry is Medical Devices.
How many shares does Novacyt have in circulation?
The max supply of Novacyt shares is 89.06M.
What is Novacyt Price to Earnings Ratio (PE Ratio)?
Novacyt PE Ratio is now.
What was Novacyt earnings per share over the trailing 12 months (TTM)?
Novacyt EPS is -0.45 USD over the trailing 12 months.
Which sector does the Novacyt company belong to?
The Novacyt sector is Healthcare.